NO331057B1 - Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. - Google Patents

Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.

Info

Publication number
NO331057B1
NO331057B1 NO20101142A NO20101142A NO331057B1 NO 331057 B1 NO331057 B1 NO 331057B1 NO 20101142 A NO20101142 A NO 20101142A NO 20101142 A NO20101142 A NO 20101142A NO 331057 B1 NO331057 B1 NO 331057B1
Authority
NO
Norway
Prior art keywords
combination preparation
hypercholesterolemia
treatment
hyperlipidemia
combination
Prior art date
Application number
NO20101142A
Other languages
English (en)
Other versions
NO20101142A1 (no
Inventor
Sigurd Strommen
Original Assignee
Naturmedical As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturmedical As filed Critical Naturmedical As
Priority to NO20101142A priority Critical patent/NO331057B1/no
Priority to PCT/NO2011/000222 priority patent/WO2012021068A1/en
Priority to EP11751960.3A priority patent/EP2603211B1/en
Publication of NO20101142A1 publication Critical patent/NO20101142A1/no
Publication of NO331057B1 publication Critical patent/NO331057B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det er beskrevet et kombinasjonspreparat til behandling av hyperlipiemi og hyperkolesterolemi omfattende pyrroziildine alkaloider og fortrinnsvis hele, deler av og/eller et uttrekk eller ekstrakt av en plante av familien Asteraceae og fortrinnsvis Gynura diverticata DC i kombinasjon med et eller flere andre lipid- og/eller kolesterolnedsettende midler. Kombinasjonspreparatet oppviser en forbedret effekt i forhold til andre syntetiske kolesterolnedsettende medikamenter.
NO20101142A 2010-08-12 2010-08-12 Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. NO331057B1 (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO20101142A NO331057B1 (no) 2010-08-12 2010-08-12 Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.
PCT/NO2011/000222 WO2012021068A1 (en) 2010-08-12 2011-08-10 Composition for treating hyperlipidemia
EP11751960.3A EP2603211B1 (en) 2010-08-12 2011-08-10 Composition for treating hyperlipidemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20101142A NO331057B1 (no) 2010-08-12 2010-08-12 Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.

Publications (2)

Publication Number Publication Date
NO20101142A1 NO20101142A1 (no) 2011-09-26
NO331057B1 true NO331057B1 (no) 2011-09-26

Family

ID=44545860

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20101142A NO331057B1 (no) 2010-08-12 2010-08-12 Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.

Country Status (3)

Country Link
EP (1) EP2603211B1 (no)
NO (1) NO331057B1 (no)
WO (1) WO2012021068A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697826B (zh) * 2012-06-18 2013-07-31 江苏省中国科学院植物研究所 一种白子菜蛋白提取物及其制备方法与应用
CN103230444B (zh) * 2013-05-15 2014-03-19 李伟权 一种降脂护肝中药组合物及其制备方法和应用
TWI558403B (zh) * 2013-06-04 2016-11-21 中央研究院 富含半乳糖脂之植物萃取物及其用途
CN105017438B (zh) * 2015-07-13 2018-10-30 青岛海洋生物医药研究院股份有限公司 一种白背三七多糖及其在制备用于免疫调节和抗肿瘤的药物和功能食品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100475232C (zh) * 2006-07-17 2009-04-08 浙江杭州鑫富药业股份有限公司 一种治疗糖尿病的口服药物及其用途
CN101278957A (zh) 2007-04-03 2008-10-08 郑乐建 白背三七提取物在于抗癌药物中的通途

Also Published As

Publication number Publication date
NO20101142A1 (no) 2011-09-26
WO2012021068A1 (en) 2012-02-16
EP2603211A1 (en) 2013-06-19
EP2603211B1 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
UA110054C2 (uk) Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування
WO2014145958A3 (en) Network-based microbial compositions and methods
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
PH12014502744A1 (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
ECSP11011340A (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
BRPI1006480A2 (pt) sistema configurado para ajustar o volume tidal da respiração de um indivíduo que respira sozinho e método para ajustar o volume tidal da respiração de um indivíduo que respira sozinho.
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
WO2014101295A3 (zh) 一种詹纳斯激酶(jaks)抑制活性的异恶唑衍生物
WO2013117744A3 (en) Methods of treating fibrosis
BR112016012489A2 (pt) cápsula, método de preparação de uma cápsula contendo flavonoides totais de desmodium styracifolium, e uso da cápsula
MX2013007436A (es) Uso de estabilizadores de glutamina.
NO331057B1 (no) Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.
GB201303868D0 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
WO2011025978A3 (en) Methods of treatment using anti-oxidized ldl antibodies
EA201792143A1 (ru) Лекарственная форма для продленного высвобождения действующих веществ
BR112012004714A2 (pt) preparação combinada de um extrato de cladódios de opuntia ficus indica e um extrato de folhas de olea europeae, e composição
BR112014029436A2 (pt) método de obtenção de extrato rico em rutina a partir de uma planta; e extrato rico em rutina de uncaria elliptica
BR112013013179A2 (pt) polimorfos de nor-udca ou bis-nor-udca, seu uso e método de preparação, bem como composições farmacêuticas que os compreendem
FR2985667B1 (fr) Composition verrou aqueuse comprenant de l'ethanol et un anticoagulant polysaccharidique
EP3006450A4 (en) Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
EA201291191A1 (ru) Фармацевтическая композиция для местного применения, содержащая гепарин
MX2015012730A (es) Composicion prebiotica y metodo de uso.
FI20105265A0 (fi) Jäähdytin ja valmistusmenetelmä
BRPI0705252A2 (pt) fitomedicamento obtido a partir de schinus terebinthifolius raddi
UA73592U (ru) Применение экстракта травы герани крупнокорневищной как средства с противовоспалительной и обезболивающей активностью

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees